๐ฐ Oche News
Page 32 - Oche News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Oche. Real-time updates on events, politics, business and more.
February 28, 2023
Saqa has given the organisation 90 days to lodge an appeal against its decision
February 24, 2023
Dimensional Fund Advisors LP decreased its position in shares of Chemed Co. (NYSE:CHE – Get Rating) by 0.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 152,175 shares of the company’s stock after selling 235 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Chemed […]
February 23, 2023
Recent advances in cancer genomics have deepened the medical community's understanding of the molecular alterations in brain tumours, more precisely subclassifying patients into specific diagnoses. Understanding
February 21, 2023
Named France's "best restaurant" by Le Fooding, LโAuberge de la Roche has one of our favorite meals near Nice.
February 20, 2023
Switzerland has offered to make some concessions as it seeks to put talks on the India-European Free Trade Association EFTA trade deal on the fast track, hoping to seal it this year as the two countries celebrate 75 years of their friendship treaty.
February 10, 2023
Basel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Roche Long Term Foundation acquired 540'000 Roche bearer shares at the price determined via an accelerated book building
February 10, 2023
Vabysmo met its primary endpoint in two clinical trials, BALATON and COMINO, showing non-inferior visual acuity gains compared to afliberceptMore Vabysmo patients showed an absence of blood vessel leakage
February 9, 2023
Read more about Ring system around dwarf planet on the edge of Solar System discovered on Devdiscourse
February 9, 2023
France's new envoy to Iran told President Ebrahim Raisi that Tehran had to immediately release seven French nationals detained in the country, the foreign ministry said after the envoy handed his credentials to the Iranian leader this week.
February 7, 2023
The COMMODORE 2 study met its co-primary efficacy endpoints, showing crovalimab achieved disease control in people with paroxysmal nocturnal haemoglobinuria (PNH) who have not been previously treated with